Polypoidal Choroidal Vasculopathy: Definition, Pathogenesis, Diagnosis, and Management.

[1]  P. Mitchell,et al.  Efficacy and Safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy in the PLANET Study: A Randomized Clinical Trial , 2018, JAMA ophthalmology.

[2]  C. Cheung,et al.  COMPARISON OF OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHIC CHANGES AFTER ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY ALONE OR IN COMBINATION WITH PHOTODYNAMIC THERAPY IN POLYPOIDAL CHOROIDAL VASCULOPATHY , 2017, Retina.

[3]  T. Wong,et al.  CHOROIDAL VASCULAR HYPERPERMEABILITY AS A PREDICTOR OF TREATMENT RESPONSE FOR POLYPOIDAL CHOROIDAL VASCULOPATHY , 2017, Retina.

[4]  Sri Gowtham Thakku,et al.  DETAILED CHARACTERIZATION OF CHOROIDAL MORPHOLOGIC AND VASCULAR FEATURES IN AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY , 2017, Retina.

[5]  Won Ki Lee,et al.  Efficacy and Safety of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: A Randomized Clinical Trial , 2017, JAMA ophthalmology.

[6]  Pachychoroid Pigment Epitheliopathy Associated With Tamoxifen. , 2017, Ophthalmic surgery, lasers & imaging retina.

[7]  Tien Yin Wong,et al.  CHARACTERIZATION AND DIFFERENTIATION OF POLYPOIDAL CHOROIDAL VASCULOPATHY USING SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY , 2017, Retina.

[8]  K. Freund,et al.  CHOROIDAL MORPHOLOGY IN EYES WITH POLYPOIDAL CHOROIDAL VASCULOPATHY AND NORMAL OR SUBNORMAL SUBFOVEAL CHOROIDAL THICKNESS , 2016, Retina.

[9]  K. Kadonosono,et al.  AFLIBERCEPT FOR POLYPOIDAL CHOROIDAL VASCULOPATHY: As Needed Versus Fixed Interval Dosing , 2016, Retina.

[10]  G. Kokame,et al.  Prospective clinical trial of Intravitreal aflibercept treatment for PolypoIdal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month results , 2016, BMC Ophthalmology.

[11]  Y. Ogura,et al.  Characteristics of Polypoidal Choroidal Vasculopathy Evaluated by Optical Coherence Tomography Angiography. , 2016, Investigative ophthalmology & visual science.

[12]  C. Cheung,et al.  Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians , 2016, Progress in Retinal and Eye Research.

[13]  Wei Liu,et al.  Evaluating Polypoidal Choroidal Vasculopathy With Optical Coherence Tomography Angiography , 2016, Investigative ophthalmology & visual science.

[14]  Subfoveal choroidal thickness as a predictor of treatment response to anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy , 2016, Graefe's Archive for Clinical and Experimental Ophthalmology.

[15]  T. Wong,et al.  Choroidal Thickness Changes in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy: A 12-Month Prospective Study. , 2016, American journal of ophthalmology.

[16]  Shanshan Yu,et al.  DISTINGUISHING POLYPOIDAL CHOROIDAL VASCULOPATHY FROM TYPICAL NEOVASCULAR AGE-RELATED MACULAR DEGENERATION BASED ON SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY , 2016, Retina.

[17]  K. Freund,et al.  EN FACE IMAGING OF PACHYCHOROID SPECTRUM DISORDERS WITH SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY , 2016, Retina.

[18]  K. Nishida,et al.  ONE-YEAR RESULTS OF INTRAVITREAL AFLIBERCEPT FOR POLYPOIDAL CHOROIDAL VASCULOPATHY , 2016, Retina.

[19]  K. Freund,et al.  Polypoidal Choroidal Vasculopathy: A Distinct Disease or Manifestation of Many? , 2016, Retina.

[20]  Ju Young Kim,et al.  Optical coherence tomography angiography in patients with polypoidal choroidal vasculopathy , 2016, Graefe's Archive for Clinical and Experimental Ophthalmology.

[21]  W. Lee,et al.  Anti-vascular endothelial growth factor monotherapy for polypoidal choroidal vasculopathy with polyps resembling grape clusters , 2016, Graefe's Archive for Clinical and Experimental Ophthalmology.

[22]  K Bailey Freund,et al.  Optical Coherence Tomography Angiography of Shallow Irregular Pigment Epithelial Detachments In Pachychoroid Spectrum Disease. , 2015, American journal of ophthalmology.

[23]  K Bailey Freund,et al.  OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF POLYPOIDAL CHOROIDAL VASCULOPATHY AND POLYPOIDAL CHOROIDAL NEOVASCULARIZATION , 2015, Retina.

[24]  Haoyu Chen,et al.  Association of Genetic Variants with Polypoidal Choroidal Vasculopathy: A Systematic Review and Updated Meta-analysis. , 2015, Ophthalmology.

[25]  H. Koizumi,et al.  One-Year Results of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy. , 2015, Ophthalmology.

[26]  Y. Oshima,et al.  INITIAL VERSUS DELAYED PHOTODYNAMIC THERAPY IN COMBINATION WITH RANIBIZUMAB FOR TREATMENT OF POLYPOIDAL CHOROIDAL VASCULOPATHY: The Fujisan Study , 2015, Retina.

[27]  C. Cheung,et al.  THREE-YEAR RESULTS OF POLYPOIDAL CHOROIDAL VASCULOPATHY TREATED WITH PHOTODYNAMIC THERAPY: Retrospective Study and Systematic Review , 2015, Retina.

[28]  M. Morrison,et al.  Analysis of Genetic and Environmental Risk Factors and Their Interactions in Korean Patients with Age-Related Macular Degeneration , 2015, PloS one.

[29]  T. Lim,et al.  IMPROVED SPECIFICITY OF POLYPOIDAL CHOROIDAL VASCULOPATHY DIAGNOSIS USING A MODIFIED EVEREST CRITERIA , 2015, Retina.

[30]  Two Subtypes of Polypoidal Choroidal Vasculopathy: Idiopathic Disease or Age-Related Macular Degeneration. , 2015, Investigative ophthalmology & visual science.

[31]  Min Zhao,et al.  Interleukin-1β Level Is Increased in Vitreous of Patients with Neovascular Age-Related Macular Degeneration (nAMD) and Polypoidal Choroidal Vasculopathy (PCV) , 2015, PloS one.

[32]  A. Tsujikawa,et al.  One-year result of aflibercept treatment on age-related macular degeneration and predictive factors for visual outcome. , 2015, American journal of ophthalmology.

[33]  E. Souied,et al.  Toward a specific classification of polypoidal choroidal vasculopathy: idiopathic disease or subtype of age-related macular degeneration. , 2015, Investigative ophthalmology & visual science.

[34]  T. Wong,et al.  Polypoidal Choroidal Vasculopathy in Asians , 2015, Journal of clinical medicine.

[35]  Tock Han Lim,et al.  EVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy , 2015, British Journal of Ophthalmology.

[36]  Feng Wen,et al.  New loci and coding variants confer risk for age-related macular degeneration in East Asians , 2015, Nature Communications.

[37]  T. Wong,et al.  The natural history of polypoidal choroidal vasculopathy: a multi-center series of untreated Asian patients , 2015, Graefe's Archive for Clinical and Experimental Ophthalmology.

[38]  K. Freund,et al.  PACHYCHOROID NEOVASCULOPATHY , 2015, Retina.

[39]  S. Sengupta,et al.  Sensitivity and Specificity of Spectral-Domain Optical Coherence Tomography in Detecting Idiopathic Polypoidal Choroidal Vasculopathy. , 2014, American journal of ophthalmology.

[40]  T. Wong,et al.  UNDERSTANDING INDOCYANINE GREEN ANGIOGRAPHY IN POLYPOIDAL CHOROIDAL VASCULOPATHY: The Group Experience With Digital Fundus Photography and Confocal Scanning Laser Ophthalmoscopy , 2014, Retina.

[41]  H. Iijima,et al.  Aqueous Humor Cytokine Levels in Patients with Polypoidal Choroidal Vasculopathy and Neovascular Age-Related Macular Degeneration , 2014, Ophthalmic Research.

[42]  J. Jonas,et al.  Polypoidal choroidal vasculopathy in adult chinese: the Beijing Eye Study. , 2014, Ophthalmology.

[43]  Kohji Nishida,et al.  En-face high-penetration optical coherence tomography imaging in polypoidal choroidal vasculopathy , 2014, British Journal of Ophthalmology.

[44]  U. Schmidt-Erfurth,et al.  Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration: outcomes in the Japanese subgroup of the VIEW 2 study , 2014, British Journal of Ophthalmology.

[45]  T. Wong,et al.  Comparison of exudative age-related macular degeneration subtypes in Japanese and French Patients: multicenter diagnosis with multimodal imaging. , 2014, American journal of ophthalmology.

[46]  P. Mitchell,et al.  Prevalence, racial variations, and risk factors of age-related macular degeneration in Singaporean Chinese, Indians, and Malays. , 2014, Ophthalmology.

[47]  T. Lim,et al.  A novel classification of the vascular patterns of polypoidal choroidal vasculopathy and its relation to clinical outcomes , 2014, British Journal of Ophthalmology.

[48]  T. Wong,et al.  A Prospective Study of Treatment Patterns and 1-Year Outcome of Asian Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy , 2014, PloS one.

[49]  M. Mandai,et al.  LAPTOP study: a 24-month trial of verteporfin versus ranibizumab for polypoidal choroidal vasculopathy. , 2014, Ophthalmology.

[50]  W. Lee,et al.  Choroidal neovascularization associated with focal choroidal excavation. , 2014, American journal of ophthalmology.

[51]  R. Klein,et al.  Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. , 2014, The Lancet. Global health.

[52]  H. Kim,et al.  Effects of choroidal vascular hyperpermeability on anti-vascular endothelial growth factor treatment for polypoidal choroidal vasculopathy. , 2013, American journal of ophthalmology.

[53]  L. Yeung,et al.  Polypoidal Choroidal Vasculopathy Exudation and Hemorrhage: Results of Monthly Ranibizumab Therapy at One Year , 2013, Ophthalmologica.

[54]  T. Hikichi,et al.  FACTORS PREDICTIVE OF OUTCOMES 1 YEAR AFTER 3 MONTHLY RANIBIZUMAB INJECTIONS AND AS-NEEDED REINJECTIONS FOR POLYPOIDAL CHOROIDAL VASCULOPATHY IN JAPANESE PATIENTS , 2013, Retina.

[55]  H. Koh,et al.  Long-term visual outcome and prognostic factors after intravitreal ranibizumab injections for polypoidal choroidal vasculopathy. , 2013, American journal of ophthalmology.

[56]  M. Yuzawa,et al.  Indocyanine green angiographic and optical coherence tomographic findings support classification of polypoidal choroidal vasculopathy into two types , 2013, Acta ophthalmologica.

[57]  K Bailey Freund,et al.  PACHYCHOROID PIGMENT EPITHELIOPATHY , 2013, Retina.

[58]  Hiroki Otsuka,et al.  Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab , 2013, BMC Ophthalmology.

[59]  W. Lee,et al.  Photodynamic therapy versus combination therapy in polypoidal choroidal vasculopathy: changes of aqueous vascular endothelial growth factor. , 2013, American journal of ophthalmology.

[60]  S. Kishi,et al.  Comparisons of outcomes with different intervals between adjunctive ranibizumab and photodynamic therapy for polypoidal choroidal vasculopathy. , 2013, American journal of ophthalmology.

[61]  W. Lee,et al.  ADJUSTED RETREATMENT OF POLYPOIDAL CHOROIDAL VASCULOPATHY AFTER COMBINATION THERAPY: Results at 3 Years , 2013, Retina.

[62]  A. Tsujikawa,et al.  Intravitreal injection of ranibizumab for recovery of macular function in eyes with subfoveal polypoidal choroidal vasculopathy. , 2013, Investigative ophthalmology & visual science.

[63]  Akira Negi,et al.  Effectiveness of intravitreal ranibizumab in exudative age-related macular degeneration (AMD): comparison between typical neovascular AMD and polypoidal choroidal vasculopathy over a 1 year follow-up , 2013, BMC Ophthalmology.

[64]  SYSTEMIC RISK FACTORS ASSOCIATED WITH POLYPOIDAL CHOROIDAL VASCULOPATHY AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATION , 2013, Retina.

[65]  P. Ruamviboonsuk,et al.  POLYPOIDAL CHOROIDAL VASCULOPATHY: Evidence-Based Guidelines for Clinical Diagnosis and Treatment , 2013, Retina.

[66]  Gabriëlle H S Buitendijk,et al.  Seven New Loci Associated with Age-Related Macular Degeneration , 2013, Nature Genetics.

[67]  Tien Yin Wong,et al.  Argon laser with and without anti-vascular endothelial growth factor therapy for extrafoveal polypoidal choroidal vasculopathy. , 2013, American journal of ophthalmology.

[68]  S. Kinoshita,et al.  Relationship between clinical characteristics of polypoidal choroidal vasculopathy and choroidal vascular hyperpermeability. , 2013, American journal of ophthalmology.

[69]  F. Shiraga.  Results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy.（共著） , 2013 .

[70]  Associations of IL-23 with polypoidal choroidal vasculopathy , 2013 .

[71]  F. Shiraga,et al.  Two-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy. , 2013, American journal of ophthalmology.

[72]  Christian Simader,et al.  Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. , 2012, Ophthalmology.

[73]  L. Yannuzzi,et al.  TYPE 1 (SUB-RETINAL PIGMENT EPITHELIAL) NEOVASCULARIZATION IN CENTRAL SEROUS CHORIORETINOPATHY MASQUERADING AS NEOVASCULAR AGE-RELATED MACULAR DEGENERATION , 2012, Retina.

[74]  Won Ki Lee,et al.  EVEREST STUDY: Efficacy and Safety of Verteporfin Photodynamic Therapy in Combination with Ranibizumab or Alone Versus Ranibizumab Monotherapy in Patients with Symptomatic Macular Polypoidal Choroidal Vasculopathy , 2012, Retina.

[75]  Hj Koh,et al.  Five‐year follow‐up results of photodynamic therapy for polypoidal choroidal vasculopathy , 2012 .

[76]  Akio Oishi,et al.  Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneration and polypoidal choroidal vasculopathy. , 2012, Investigative ophthalmology & visual science.

[77]  Jong Woo Kim,et al.  Short-term Effectiveness of Intravitreal Bevacizumab vs. Ranibizumab Injections for Patients with Polypoidal Choroidal Vasculopathy , 2012, Korean journal of ophthalmology : KJO.

[78]  K. Freund,et al.  POLYPOIDAL CHOROIDAL VASCULOPATHY: Simultaneous Indocyanine Green Angiography and Eye-Tracked Spectral Domain Optical Coherence Tomography Findings , 2012, Retina.

[79]  L. Yannuzzi,et al.  Idiopathic polypoidal choroidal vasculopathy (IPCV). 1990. , 2012, Retina.

[80]  A. Tsujikawa,et al.  Treatment of polypoidal choroidal vasculopathy with photodynamic therapy combined with intravitreal injections of ranibizumab. , 2012, American journal of ophthalmology.

[81]  Soon-Sun Kwon,et al.  COMPARISON OF CHOROIDAL THICKNESS AMONG PATIENTS WITH HEALTHY EYES, EARLY AGE-RELATED MACULOPATHY, NEOVASCULAR AGE-RELATED MACULAR DEGENERATION, CENTRAL SEROUS CHORIORETINOPATHY, AND POLYPOIDAL CHOROIDAL VASCULOPATHY , 2011, Retina.

[82]  Amrita,et al.  Increased expression of multifunctional serine protease, HTRA1, in retinal pigment epithelium induces polypoidal choroidal vasculopathy in mice , 2011, Proceedings of the National Academy of Sciences.

[83]  T. Wong,et al.  Relationship of smoking and cardiovascular risk factors with polypoidal choroidal vasculopathy and age-related macular degeneration in Chinese persons. , 2011, Ophthalmology.

[84]  Chi-Hsien Peng,et al.  ONE-YEAR OUTCOMES OF INTRAVITREAL BEVACIZUMAB (AVASTIN) THERAPY FOR POLYPOIDAL CHOROIDAL VASCULOPATHY , 2011, Retina.

[85]  Se Woong Kang,et al.  Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration. , 2011, Ophthalmology.

[86]  R. Kawasaki,et al.  Subfoveal choroidal thickness in typical age-related macular degeneration and polypoidal choroidal vasculopathy , 2010, Graefe's Archive for Clinical and Experimental Ophthalmology.

[87]  K Bailey Freund,et al.  Do We Need a New Classification for Choroidal Neovascularization in Age-Related Macular Degeneration? , 2010, Retina.

[88]  J. Chhablani.  Photodynamic therapy for polypoidal choroidal vasculopathy , 2010, Graefe's Archive for Clinical and Experimental Ophthalmology.

[89]  S. Byeon,et al.  Clinical features and follow‐up results of pulsating polypoidal choroidal vasculopathy treated with photodynamic therapy , 2010, Acta ophthalmologica.

[90]  J. Cunha-Vaz,et al.  PHOTODYNAMIC THERAPY WITH VERTEPORFIN IN POLYPOIDAL CHOROIDAL VASCULOPATHY: Results After 3 Years of Follow-Up , 2010, Retina.

[91]  T. Wakabayashi,et al.  Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy. , 2010, American journal of ophthalmology.

[92]  K. Horie-Inoue,et al.  Phenotype and genotype characteristics of age-related macular degeneration in a Japanese population. , 2010, Ophthalmology.

[93]  Augustinus Laude,et al.  Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: Same or different disease? , 2010, Progress in Retinal and Eye Research.

[94]  山下 彩奈.  One-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy , 2010 .

[95]  小澤 信介.  Differences in macular morphology between polypoidal choroidal vasculopathy and exudative age-related macular degeneration detected by optical coherence tomography , 2010 .

[96]  Photodynamic therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy: A 30-month multicenter study in Hyogo, Japan , 2009, Japanese Journal of Ophthalmology.

[97]  Takuhiro Yamaguchi,et al.  Background comparison of typical age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients. , 2009, Ophthalmology.

[98]  Wen-Chuan Wu,et al.  Polypoidal choroidal vasculopathy in Taiwanese patients. , 2009, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.

[99]  H. Yamashita,et al.  TWO-YEAR VISUAL OUTCOMES AFTER PHOTODYNAMIC THERAPY IN AGE-RELATED MACULAR DEGENERATION PATIENTS WITH OR WITHOUT POLYPOIDAL CHOROIDAL VASCULOPATHY LESIONS , 2009, Retina.

[100]  Seong-Woo Kim,et al.  Retinal pigment epithelial tear after half fluence PDT for serous pigment epithelial detachment in central serous chorioretinopathy. , 2009, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.

[101]  I. Yeo,et al.  A CLASSIFICATION SYSTEM FOR POLYPOIDAL CHOROIDAL VASCULOPATHY , 2009, Retina.

[102]  Y. Tano,et al.  One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients. , 2010, Ophthalmology.

[103]  Hiroyuki Shimada,et al.  Clinicopathologic findings in polypoidal choroidal vasculopathy. , 2008, Investigative ophthalmology & visual science.

[104]  Acute Visual Loss and Chorioretinal Infarction after Photodynamic Therapy Combined with Intravitreal Triamcinolone , 2008, European journal of ophthalmology.

[105]  Y. Tano,et al.  Marked vascular changes of polypoidal choroidal vasculopathy after photodynamic therapy , 2008, British Journal of Ophthalmology.

[106]  T. Lai,et al.  Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy , 2008, British Journal of Ophthalmology.

[107]  S. C. Lee,et al.  Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patients , 2008, Japanese Journal of Ophthalmology.

[108]  N. Hamajima,et al.  Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration. , 2007, Ophthalmology.

[109]  K. Fujita,et al.  Role of Photodynamic Therapy in Polypoidal Choroidal Vasculopathy , 2007, Japanese Journal of Ophthalmology.

[110]  I. Maruko,et al.  Clinical characteristics of exudative age-related macular degeneration in Japanese patients. , 2007, American journal of ophthalmology.

[111]  Y. Tano,et al.  Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy , 2007, British Journal of Ophthalmology.

[112]  S. Kishi,et al.  TOMOGRAPHIC FEATURES OF BRANCHING VASCULAR NETWORKS IN POLYPOIDAL CHOROIDAL VASCULOPATHY , 2007, Retina.

[113]  F. Wen,et al.  Subtype lesions of neovascular age-related macular degeneration in Chinese patients , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.

[114]  Y. Tano,et al.  Angiographic lesion of polypoidal choroidal vasculopathy on indocyanine green and fluorescein angiography , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.

[115]  Gerald Liew,et al.  Ranibizumab for neovascular age-related macular degeneration. , 2007, The New England journal of medicine.

[116]  M. Mandai,et al.  Pigment epithelial detachment in polypoidal choroidal vasculopathy. , 2007, American journal of ophthalmology.

[117]  A. Ruby,et al.  SELF-REPORTED ACUTE DECREASE IN VISUAL ACUITY AFTER PHOTODYNAMIC THERAPY FOR AGE-RELATED MACULAR DEGENERATION , 2006, Retina.

[118]  Susan Schneider,et al.  Ranibizumab versus verteporfin for neovascular age-related macular degeneration. , 2006, The New England journal of medicine.

[119]  M. Mandai,et al.  Polypoidal choroidal vasculopathy with choroidal vascular hyperpermeability. , 2006, American journal of ophthalmology.

[120]  K. Choy,et al.  Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. , 2006, American journal of ophthalmology.

[121]  Michael D. Ober,et al.  Choroidal infarction following photodynamic therapy with verteporfin. , 2005, Archives of ophthalmology.

[122]  M. Yuzawa,et al.  The origins of polypoidal choroidal vasculopathy , 2005, British Journal of Ophthalmology.

[123]  J. Cunha-Vaz,et al.  Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[124]  T. Lai,et al.  Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series. , 2004, Ophthalmology.

[125]  N. Yoshimura,et al.  Pathological features of surgically excised polypoidal choroidal vasculopathy membranes , 2004, Clinical & experimental ophthalmology.

[126]  M. Matsumura,et al.  Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy , 2004, British Journal of Ophthalmology.

[127]  O. Ruiz-Moreno,et al.  [Idiopathic polypoidal choroidal vasculopathy]. , 2004, Archivos de la Sociedad Espanola de Oftalmologia.

[128]  Haitao Li,et al.  Polypoidal choroidal vasculopathy in elderly Chinese patients , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.

[129]  M. Matsumura,et al.  Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics. , 2003, Archives of ophthalmology.

[130]  George A. Williams,et al.  IMMEDIATE INDOCYANINE GREEN ANGIOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY EVALUATION AFTER PHOTODYNAMIC THERAPY FOR SUBFOVEAL CHOROIDAL NEOVASCULARIZATION , 2003, Retina.

[131]  L. Yannuzzi,et al.  Polypoidal choroidal vasculopathy. , 2002, Ophthalmology clinics of North America.

[132]  A. Okubo,et al.  Clinicopathological correlation of polypoidal choroidal vasculopathy revealed by ultrastructural study , 2002, The British journal of ophthalmology.

[133]  U. Schmidt-Erfurth,et al.  Histopathological changes following photodynamic therapy in human eyes. , 2002, Archives of ophthalmology.

[134]  M. Matsumura,et al.  Polypoidal choroidal vasculopathy: natural history. , 2002, American journal of ophthalmology.

[135]  Janet L. Davis,et al.  Clinicopathologic correlation of idiopathic polypoidal choroidal vasculopathy , 2002 .

[136]  Y. Miyake,et al.  Polypoidal choroidal vasculopathy treated with macular translocation: clinical pathological correlation , 2002, The British journal of ophthalmology.

[137]  Janet L. Davis,et al.  Clinicopathologic reports, case reports, and small case series: clinicopathologic correlation of idiopathic polypoidal choroidal vasculopathy. , 2002, Archives of ophthalmology.

[138]  A. Bird,et al.  Polypoidal choroidal vasculopathy and central serous chorioretinopathy. , 2001, Ophthalmology.

[139]  M. F. Shuler.  Polypoidal Choroidal Vasculopathy Masquerading as Central Serous Chorioretinopathy , 2001 .

[140]  B. Lafaut,et al.  Polypoidal choroidal vasculopathy in Caucasians , 2000, Graefe's Archive for Clinical and Experimental Ophthalmology.

[141]  J. Slakter,et al.  Polypoidal choroidal vasculopathy masquerading as central serous chorioretinopathy. , 2000, Ophthalmology.

[142]  L A Yannuzzi,et al.  Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration. , 1999, Archives of ophthalmology.

[143]  J. Slakter,et al.  INDOCYANINE GREEN VIDEOANGIOGRAPHY OF IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY , 1995, Retina.

[144]  N. Bressler,et al.  CLINICOPATHOLOGIC CORRELATION OF THE MULTIPLE RECURRENT SEROSANGUINEOUS RETINAL PIGMENT EPITHELIAL DETACHMENTS SYNDROME , 1994, Retina.

[145]  A. Brucker,et al.  THE POSTERIOR UVEAL BLEEDING SYNDROME , 1990, Retina.